JJ Pharma, Inc. is a biopharmaceutical company developing small molecule therapeutics to treat diseases with significant unmet needs in the areas of metabolic disorders including metabolic syndrome, chronic heart disease (CHD) and diabetes.
We seek to minimize the time, expense and technical risk associated with drug commercialization by using rational chemical design to synthesize molecules with the highest probability of becoming drug candidates.
JJ Pharma presented at the Southern California Investment Association's National Small Cap Syndicate on April 14, 2008 - Watch Now »
Copyright © JJ Pharma, Inc.
Template By Zymic.com